CMV-hRad51 Citations (3)

Originally described in: Development of hRad51-Cas9 nickase fusions that mediate HDR without double-stranded breaks.
Rees HA, Yeh WH, Liu DR Nat Commun. 2019 May 17;10(1):2212. doi: 10.1038/s41467-019-09983-4. PubMed Journal

---

Articles Citing CMV-hRad51

Articles
Novel fluorescent-based reporter cell line engineered for monitoring homologous recombination events. Bernardi A, Gobelli D, Serna J, Nawrocka P, March-Rossello G, Orduna A, Kozlowski P, Simarro M, de la Fuente MA. PLoS One. 2021 Apr 30;16(4):e0237413. doi: 10.1371/journal.pone.0237413. eCollection 2021. PubMed
Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian Cancer. Bai S, Taylor SE, Jamalruddin MA, McGonigal S, Grimley E, Yang D, Bernstein KA, Buckanovich RJ. Mol Cancer Ther. 2022 Sep 6;21(9):1473-1484. doi: 10.1158/1535-7163.MCT-21-0873. PubMed
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer. Jacoberger-Foissac C, Cousineau I, Bareche Y, Allard D, Chrobak P, Allard B, Pommey S, Messaoudi N, McNicoll Y, Soucy G, Koseoglu S, Masia R, Lake AC, Seo H, Eeles CB, Rohatgi N, Robson SC, Turcotte S, Haibe-Kains B, Stagg J. Cancer Immunol Res. 2023 Jan 3;11(1):56-71. doi: 10.1158/2326-6066.CIR-22-0260. PubMed

If you have published an article using this material, please email us at to have your article added to this page.